Low-dose Oral Interferon may Prevent Relapse of Hepatitis C Virus Infection

Chronic hepatitis C virus (HCV) infection can lead to serious diseases such as cancer of the liver and cirrhosis, so viral clearance and prevention of relapse are important treatment goals.

Low-dose oral interferon may reduce the risk of HCV relapse in patients with mild liver fibrosis according to a study published in Journal of Interferon & Cytokine Research, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Interferon & Cytokine Research website.

Hepatitis C Surface Protein Structure Identified by Rutgers Researchers
Researchers at Rutgers University have identified the structure of the surface protein of the virus.

In "A Double-Blind Randomized Controlled Study to Evaluate the Efficacy of Low-Dose Oral Interferon-Alpha in Preventing Hepatitis C Relapse," Chuan-Mo Lee and coauthors from several universities and hospitals in Taiwan present the results of a clinical trial comparing the effects of 24 weeks of treatment with two doses of oral interferon-alpha or placebo in patients who achieved viral clearance after successful HCV therapy.

"This is a highly significant study relevant to the optimal use of IFN for HCV treatment," says Co-Editor-in-Chief Ganes C. Sen, PhD, Chairman, Department of Molecular Genetics, Cleveland Clinic Foundation, Ohio.

Source-Eurekalert

New Tactics Found in Offense-Defense Struggle With Hepatitis C Virus
Hepatitis C virus (HCV) has a previously unrecognized tactic to outwit antiviral responses and may sustain a long-term infection.

Hepatitis C Soon to be Cured Using a Single Pill
A combination of pills, still in the experimental phase, are supposedly effective at curing hepatitis C, a new study found

Revised Clinical Practice Guidelines to Optimize the Management of Hepatitis C Virus Published By EASL
The revised Clinical Practice Guidelines (CPGs) on the management of hepatitis C virus infection (HCV) (1) were published by the European Association for the Study of the Liver (EASL).